参考文献/References:
[1] DIXON S J,LEMBERG K M,LAMPRECHT M R,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
[2] STOCKWELL B R,FRIEDMANN ANGELI J P,BAYIR H,et al.Ferroptosis:a regulated cell death nexus linking metabolism,redox biology,and disease[J].Cell,2017,171(2):273-285.
[3] CHEN H,YANG X,LU K,et al.Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice[J].Toxicol Lett,2017,278:48-58.
[4] CHEN Q M,MALTAGLIATI A J.Nrf2 at the heart of oxidative stress and cardiac protection[J].Physiol Genomics,2018,50(2):77-97.
[5] FAN Z,WIRTH A K,CHEN D,et al.Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis[J].Oncogenesis,2017,6(8):e371.
[6] ABDALKADER M,LAMPINEN R,KANNINEN K M,et al.Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration[J].Front Neurosci,2018,12:466.
[7] HU X,RAJESH M,ZHANG J,et al.Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2[J].Toxicol Lett,2018,287:131-141.
[8] WANG G,SONG X,ZHAO L,et al.Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity[J].Biomed Res Int,2018,2018:2150218.
[9] ZANG H,WU W,QI L,et al.Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice[J].Diabetes,2020,69(12):2720-2734.
[10] LI Z,CHEN L,CHEN C,et al.Targeting ferroptosis in breast cancer[J].Biomark Res,2020,8(1):58.
[11] TANG D,CHEN X,KANG R,et al.Ferroptosis:molecular mechanisms and health implications[J].Cell Res,2021,31(2):107-125.
[12] JIANG M,HU R,YU R,et al.A narrative review of mechanisms of ferroptosis in cancer:new challenges and opportunities[J].Ann Transl Med,2021,9(20):1599.
[13] KAJARABILLE N,LATUNDE-DADA G O.Programmed cell-death by ferroptosis:antioxidants as mitigators[J].Int J Mol Sci,2019,20(19):4968.
[14] GAO M,MONIAN P,QUADRI N,et al.Glutaminolysis and transferrin regulate ferroptosis[J].Mol Cell,2015,59(2):298-308.
[15] BOGDAN A R,MIYAZAWA M,HASHIMOTO K,et al.Regulators of iron homeostasis:new players in metabolism,cell death,and disease[J].Trends Biochem Sci,2016,41(3):274-286.
[16] SHEN Z,LIU T,LI Y,et al.Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors[J].ACS Nano,2018,12(11):11355-11365.
[17] LATUNDE-DADA G O.Ferroptosis:role of lipid peroxidation,iron and ferritinophagy[J].Biochim Biophys Acta Gen Subj,2017,1861(8):1893-1900.
[18] LIANG C,ZHANG X,YANG M,et al.Recent progress in ferroptosis inducers for cancer therapy[J].Adv Mater,2019,31(51):e1904197.
[19] KAGAN V E,MAO G,QU F,et al.Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J].Nat Chem Biol,2017,13(1):81-90.
[20] DIXON S J,WINTER G E,MUSAVI L S,et al.Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death[J].ACS Chem Biol,2015,10(7):1604-1609.
[21] DOLL S,PRONETH B,TYURINA Y Y,et al.ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J].Nat Chem Biol,2017,13(1):91-98.
[22] SHINTOKU R,TAKIGAWA Y,YAMADA K,et al.Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3[J].Cancer Sci,2017,108(11):2187-2194.
[23] SHAH R,SHCHEPINOV M S,PRATT D A.Resolving the role of lipoxygenases in the initiation and execution of ferroptosis[J].ACS Cent Sci,2018,4(3):387-396.
[24] ZOU Y,LI H,GRAHAM E T,et al.Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis[J].Nat Chem Biol,2020,16(3):302-309.
[25] YAN B,AI Y,SUN Q,et al.Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1[J].Mol Cell,2021,81(2):355-369.e10.
[26] LI J,CAO F,YIN H,et al.Ferroptosis:past,present and future[J].Cell Death Dis,2020,11(2):88.
[27] BRIDGES R,LUTGEN V,LOBNER D,et al.Thinking outside the cleft to understand synaptic activity:contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling[J].Pharmacol Rev,2012,64(3):780-802.
[28] SEIBT T M,PRONETH B,CONRAD M.Role of GPX4 in ferroptosis and its pharmacological implication[J].Free Radic Biol Med,2019,133:144-152.
[29] LI N,JIANG W,WANG W,et al.Ferroptosis and its emerging roles in cardiovascular diseases[J].Pharmacol Res,2021,166:105466.
[30] INGOLD I,BERNDT C,SCHMITT S,et al.Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis[J].Cell,2018,172(3):409-422.e21.
[31] LIU X,ZHANG Y,ZHUANG L,et al.NADPH debt drives redox bankruptcy:SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation[J].Genes Dis,2021,8(6):731-745.
[32] JIA G,HILL M A,SOWERS J R.Diabetic cardiomyopathy:an update of mechanisms contributing to this clinical entity[J].Circ Res,2018,122(4):624-638.
[33] BOUDINA S,ABEL E D.Diabetic cardiomyopathy revisited[J].Circulation,2007,115(25):3213-3223.
[34] KANNEL W B,HJORTLAND M,CASTELLI W P.Role of diabetes in congestive heart failure:the Framingham study[J].Am J Cardiol,1974,34(1):29-34.
[35] TARQUINI R,PALA L,BRANCATI S,et al.Clinical approach to diabetic cardiomyopathy:a review of human studies[J].Curr Med Chem,2018,25(13):1510-1524.
[36] RITCHIE R H,ABEL E D.Basic mechanisms of diabetic heart disease[J].Circ Res,2020,126(11):1501-1525.
[37] ANEJA A,TANG W H W,BANSILAL S,et al.Diabetic cardiomyopathy:insights into pathogenesis,diagnostic challenges,and therapeutic options[J].Am J Med,2008,121(9):748-757.
[38] LI W,LI W,LENG Y,et al.Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress[J].DNA Cell Biol,2020,39(2):210-225.
[39] WU H,WANG F,TA N,et al.The multifaceted regulation of mitochondria in ferroptosis[J].Life,2021,11(3):222.
[40] ZOU C,LIU X,XIE R,et al.Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats[J].Biochem Biophys Res Commun,2017,486(4):930-936.
[41] WANG S Y,ZHU S,WU J,et al.Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy[J].J Mol Med (Berl),2020,98(2):245-261.
[42] SHAH M S,BROWNLEE M.Molecular and cellular mechanisms of cardiovascular disorders in diabetes[J].Circ Res,2016,118(11):1808-1829.
[43] DIXON S J,STOCKWELL B R.The hallmarks of ferroptosis[J].Annu Rev Cancer Biol,2019,3:35-54.
[44] DODSON M,CASTRO-PORTUGUEZ R,ZHANG D D.NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis[J].Redox Biol,2019,23:101107.
[45] ZANG H,MATHEW R O,CUI T.The dark side of Nrf2 in the heart[J].Front Physiol,2020,11:722.
[46] GAO L,LIU Y,GUO S,et al.LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(10):3322-3338.
[47] QIAO S,OLSON J M,PATERSON M,et al.MicroRNA-21 mediates isoflurane-induced cardioprotection against ischemia-reperfusion injury via akt/nitric oxide synthase/mitochondrial permeability transition pore pathway[J].Anesthesiology,2015,123(4):786-798.
[48] OLSON J M,YAN Y,BAI X,et al.Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes[J].Anesthesiology,2015,122(4):795-805.
[49] SEKAR D,VENUGOPAL B,SEKAR P,et al.Role of microRNA 21 in diabetes and associated/related diseases[J].Gene,2016,582(1):14-18.
[50] GE Z D,LI Y,QIAO S,et al.Failure of isoflurane cardiac preconditioning in obese type 2 diabetic mice involves aberrant regulation of microRNA-21,endothelial nitric-oxide synthase,and mitochondrial complex I[J].Anesthesiology,2018,128(1):117-129.
[51] ERKENS R,KRAMER C M,LCKSTDT W,et al.Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy,decreased expression of SERCA2a,and preserved endothelial function[J].Free Radic Biol Med,2015,89:906-917.
[52] DAVID J A,RIFKIN W J,RABBANI P S,et al.The Nrf2/Keap1/ARE pathway and oxidative stress as a therapeutic target in type II diabetes mellitus[J].J Diabetes Res,2017,2017:1-15.
[53] DLUDLA P V,MULLER C J,JOUBERT E,et al.Aspalathin protects the heart against hyperglycemia-induced oxidative damage by up-regulating Nrf2 expression[J].Molecules,2017,22(1):129.
[54] ZHANG Z,ZHOU S,JIANG X,et al.The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome[J].Rev Endocr Metab Disord,2015,16(1):35-45.
[55] WANG N,MA H,LI J,et al.HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes[J].J Mol Cell Cardiol,2021,150:65-76.
[56] BERSUKER K,HENDRICKS J M,LI Z,et al.The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J].Nature,2019,575(7784):688-692.
[57] HUYNH K,KIRIAZIS H,DU X J,et al.Coenzyme Q10 attenuates diastolic dysfunction,cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes[J].Diabetologia,2012,55(5):1544-1553.
[58] SHIRPOOR A,SALAMI S,KHADEM-ANSARI M H,et al.Cardioprotective effect of vitamin E:rescues of diabetes-induced cardiac malfunction,oxidative stress,and apoptosis in rat[J].J Diabetes Complications,2009,23(5):310-316.
[59] JENKINS T,GOUGE J.Nrf2 in cancer,detoxifying enzymes and cell death programs[J].Antioxidants,2021,10(7):1030.
[60] GU J,CHENG Y,WU H,et al.Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy[J].Diabetes,2017,66(2):529-542.
[61] WANG Y,CHEN J,LI S,et al.Exogenous spermine attenuates rat diabetic cardiomyopathy via suppressing ROS-p53 mediated downregulation of calcium-sensitive receptor[J].Redox Biol,2020,32:101514.
[62] DUAN J Y,LIN X,XU F,et al.Ferroptosis and its potential role in metabolic diseases:a curse or revitalization?[J].Front Cell Dev Biol,2021,9:701788.
[63] CUADRADO A,MARTN-MOLDES Z,YE J,et al.Transcription factors NRF2 and NF-κB are coordinated effectors of the Rho family,GTP-binding protein RAC1 during inflammation[J].J Biol Chem,2014,289(22):15244-15258.
[64] STEELE M L,FULLER S,PATEL M,et al.Effect of Nrf2 activators on release of glutathione,cysteinylglycine and homocysteine by human U373 astroglial cells[J].Redox Biol,2013,1(1):441-445.
[65] CHIN M P,BAKRIS G L,BLOCK G A,et al.Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes:post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study[J].Am J Nephrol,2018,47(1):40-47.
[66] OHKUMA T,PETERS S A E,WOODWARD M.Sex differences in the association between diabetes and cancer:a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events[J].Diabetologia,2018,61(10):2140-2154.
[67] WANG H,LIU X,LONG M,et al.NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis[J].Sci Transl Med,2016,8(334):334ra51.